Download Files:
Products Details
Product Description
– Cinsebrutinib is a Bruton’s tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study.
Web ID
– HY-156604
Shipping
– Room temperature
Molecular Formula
– C22H26FN3O2
References
– [1]Coburn, Craig Alan, et al. Preparation of pyridoindolecarboxamides and their analogs as BTK kinase inhibitors. WO2021207549.
CAS Number
– 2724962-58-5
Molecular Weight
– 383.46
SMILES
– FC1=CC(C(N)=O)=C(NC2=C3CCCCC2)C3=C1[C@H]4CN(CCC4)C(C=C)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
